Larry Onyango Akoko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Larry Onyango Akoko has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Ally Mwanga
Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania
15 shared publications - Elia John Mmbaga
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
14 shared publications - Katherine Van Loon
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
14 shared publications - Beatrice Paul Mushi
Department of Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
13 shared publications - Julius Mwaiselage
Ocean Road Cancer Institute, Dar es Salaam P.O. Box 3592, Tanzania
13 shared publications - Amie Radenbaugh
NantOmics/NantHealth, Inc., El Segundo, California
12 shared publications
Latest Publications
- Open Access
- 20 November 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1)
Antibiotic duration after laparotomy at a tertiary hospital in Tanzania, a prospective observational cohort study
- 20 November 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1)
Open AccessAntibiotic duration after laparotomy at a tertiary hospital in Tanzania, a prospective observational cohort study
- Open Access
- 12 September 2026
- Published by Elsevier in Surgery Open Digestive Advance
- Vol. 21
Determinants of preoperative care timelines in emergency abdominal surgery in Tanzania
- 12 September 2026
- Published by Elsevier in Surgery Open Digestive Advance
- Vol. 21
Open AccessDeterminants of preoperative care timelines in emergency abdominal surgery in Tanzania
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S2. Expression of Mutsig CV genes in cohorts from Tanzania (Panel A) and Malawi (Panel B).
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S2. Expression of Mutsig CV genes in cohorts from Tanzania (Panel A) and Malawi (Panel B).
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S1. Measurement of RNA Quantity and Quality using PAXgene tissue container vs. RNAlater.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S1. Measurement of RNA Quantity and Quality using PAXgene tissue container vs. RNAlater.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Data from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Background:Esophageal squamous cell carcinoma (ESCC) comprises 90% of all esophageal cancer cases globally and is the most common histology in low-resource settings. Eastern Africa has a disproportionately high incidence of ESCC.Methods:We describe the genomic profiles of 61 ESCC cases from Tanzania and compare them to profiles from an existing cohort of ESCC cases from Malawi. We also provide a comparison to ESCC tumors in The Cancer Genome Atlas (TCGA).Results:We observed substantial transcriptional overlap with other squamous histologies via comparison with TCGA PanCan dataset. DNA analysis revealed known mutational patterns, both genome-wide as well as in genes known to be commonly mutated in ESCC. TP53 mutations were the most common somatic mutation in tumors from both Tanzania and Malawi but were detected at lower frequencies than previously reported in ESCC cases from other settings. In a combined analysis, two unique transcriptional clusters were identified: a proliferative/epithelial cluster and an invasive/migrative/mesenchymal cluster. Mutational signature analysis of the Tanzanian cohort revealed common signatures associated with aging and cytidine deaminase activity (APOBEC) and an absence of signature 29, which was previously reported in the Malawi cohort.Conclusions:This study defines the molecular characteristics of ESCC in Tanzania, and enriches the Eastern African dataset, with findings of overall similarities but also some heterogeneity across two unique sites.Impact:Despite a high burden of ESCC in Eastern Africa, investigations into the genomics in this region are nascent. This represents the largest comprehensive genomic analysis ESCC from sub-Saharan Africa to date.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Background:Esophageal squamous cell carcinoma (ESCC) comprises 90% of all esophageal cancer cases globally and is the most common histology in low-resource settings. Eastern Africa has a disproportionately high incidence of ESCC.Methods:We describe the genomic profiles of 61 ESCC cases from Tanzania and compare them to profiles from an existing cohort of ESCC cases from Malawi. We also provide a comparison to ESCC tumors in The Cancer Genome Atlas (TCGA).Results:We observed substantial transcriptional overlap with other squamous histologies via comparison with TCGA PanCan dataset. DNA analysis revealed known mutational patterns, both genome-wide as well as in genes known to be commonly mutated in ESCC. TP53 mutations were the most common somatic mutation in tumors from both Tanzania and Malawi but were detected at lower frequencies than previously reported in ESCC cases from other settings. In a combined analysis, two unique transcriptional clusters were identified: a proliferative/epithelial cluster and an invasive/migrative/mesenchymal cluster. Mutational signature analysis of the Tanzanian cohort revealed common signatures associated with aging and cytidine deaminase activity (APOBEC) and an absence of signature 29, which was previously reported in the Malawi cohort.Conclusions:This study defines the molecular characteristics of ESCC in Tanzania, and enriches the Eastern African dataset, with findings of overall similarities but also some heterogeneity across two unique sites.Impact:Despite a high burden of ESCC in Eastern Africa, investigations into the genomics in this region are nascent. This represents the largest comprehensive genomic analysis ESCC from sub-Saharan Africa to date.
- 5 August 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (10) , 110368
The surgical implications of advanced cancers in low- and middle-income countries: Challenges, opportunities, and call to action
- 5 August 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (10) , 110368
The surgical implications of advanced cancers in low- and middle-income countries: Challenges, opportunities, and call to action
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S1. Measurement of RNA Quantity and Quality using PAXgene tissue container vs. RNAlater.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S1. Measurement of RNA Quantity and Quality using PAXgene tissue container vs. RNAlater.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S2. Expression of Mutsig CV genes in cohorts from Tanzania (Panel A) and Malawi (Panel B).
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S2. Expression of Mutsig CV genes in cohorts from Tanzania (Panel A) and Malawi (Panel B).
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S1. Measurement of RNA Quantity and Quality using PAXgene tissue container vs. RNAlater.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S1. Measurement of RNA Quantity and Quality using PAXgene tissue container vs. RNAlater.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S2. Expression of Mutsig CV genes in cohorts from Tanzania (Panel A) and Malawi (Panel B).
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa
Supplementary Figure S2. Expression of Mutsig CV genes in cohorts from Tanzania (Panel A) and Malawi (Panel B).